Evidence map›Paper›PMID 42282034›Full record

ArticleResearch square2026

Microglia regulate adult neurogenesis via interleukin-6

Rudolph Tanzi, Ryan Castro, Evan Gavrilles, Se Hoon Choi

Abstract readPreprint
In one paragraph

Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rudolph TanziMassachusetts General Hospital.ORCID 0000-0002-7032-1454
Ryan CastroMassachusetts General Hospital.
Evan GavrillesMassachusetts General Hospital.
Se Hoon ChoiMassachusetts General Hospital, Harvard Medical School.

Funding

Resilience to Alzheimer's disease by targeting adult hippocampal neurogenesisRF1AG085291 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI CHOI, SE HOON, HIDE, WINSTON ALEXANDER · 2024 to 2024
$2.2M
Cellular and molecular changes in the spinal cord that cause motor deficits in old ageK00AG068442 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI CASTRO, RYAN · 2023 to 2025
$244k
NIA NIH HHS K00 AG068442NIA NIH HHS RF1 AG085291
6 · The paper itself

Abstract

In the adult hippocampus, neural progenitor cells (NPCs) proliferate before undergoing differentiation, maturation, and incorporation into the hippocampal neurocircuitry, where they contribute to diverse learning and memory processes that can be perturbed by injury, aging, and disease (1-10). Recent advances have identified microglia and interleukin-6 (IL-6) as regulators of adult hippocampal neurogenesis (AHN) (11). Despite these findings, the mechanism by which IL-6 signaling or microglia regulate neurogenesis has remained unclear. Here, we show that IL-6 trans signaling is triggered by microglial IL-6R shedding during efferocytosis, and that this mediates the transition from proliferation to neuronal differentiation in neighboring, healthy NPCs. We found that proliferating NPCs secrete IL-6 and that apoptotic NPCs are commonly found within clusters of proliferating NPCs. Next, we show that efferocytosis of apoptotic NPCs causes IL-6 receptor shedding by microglia and that IL-6 trans activation of NPCs leads to neuronal differentiation and maturation. Finally, we generated transgenic mice lacking IL-6R exclusively in microglia and found impaired neuronal maturation in the adult hippocampus and deficits in learning and memory in these mice. Our results reveal a molecular mechanism by which microglia regulate adult neurogenesis and contextualize myriad separate investigations into the role of microglia and IL-6 in neurogenesis. Our results position microglia not merely as passive responders to cell death but as active regulators of lineage specification and progenitor cell maturation within the neurogenic niche. The IL-6 trans signaling axis appears to function as a temporally gated checkpoint that coordinates niche refinement-balancing expansion with maturation and synchronizing neuronal development with microglial activation and quiescence. These results could be utilized to develop treatments in pathological contexts characterized by deficits in neurogenesis, such as Alzheimer's disease.

Identifiers

PMID42282034
PMCPMC13252529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.